An international panel of the foremost researchers on infectious disease and antimicrobials has formed new guidelines on the use of polymyxins, a class of antibiotics employed as a last resort to treat...

Antibiotic resistance is spreading from wastewater treatment plants The products of wastewater treatment have been found to contain trace amounts of antibiotic resistant DNA. These products are often...

The US Food and Drug Administration (FDA) issued a safety alert today concerning the dosing of the rheumatoid arthritis (RA) drug, Xeljanz and Xeljanz XR. A safety clinical trial found an increased risk...

A commonly used medication, fluconazole, used to treat vaginal yeast infections, is linked to higher rates of miscarriage if used during pregnancy, found new research published in CMAJ (Canadian Medical...

In a follow-up on the Dengvaxia situation in the Philippines, the Food and Drug Administration (FDA) reports permanently revoking the Certificates of Product Registration (CPR) of dengue vaccine Dengvaxia...

Novartis announced this week the approval of Egaten® (triclabendazole) by the US Food and Drug Administration (FDA) for the treatment of fascioliasis in patients six years of age and older. Egaten is...

Newborns infected with herpes simplex virus (HSV) can be appropriately treated with acyclovir, a drug typically prescribed to adults for the treatment of HSV infections. Acyclovir’s drug label now includes...

Merck announced this week that the U.S. Food and Drug Administration (FDA) has accepted for review regulatory filings for two antibacterial agents. These filings are: (1) a NDA accepted for Priority Review...

Australian company, Mayne Pharma announced this week that their antifungal drug, TOLSURA™ (SUBA®-itraconazole) 65mg capsule, will be launched in the United States. TOLSURA is a new formulation of...

The investigational Ebola treatment mAb114 is safe, well-tolerated, and easy to administer, according to findings from an early-stage clinical trial published in The Lancet. Eighteen healthy adults...